Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults

NCT07675629 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Prevention

Interventions

BIOLOGICAL: PDPHV Plasmid DNA Vaccines (env (A, B, C, A/E)/gag (C))
BIOLOGICAL: PDPHV Recombinant Protein Vaccines (gp120 (A, B, C, A/E))
BIOLOGICAL: Alhydrogel adjuvant
BIOLOGICAL: GLA-SE adjuvant
BIOLOGICAL: Placebo for DNA Vaccines, Protein Vaccines and Adjuvants

Sponsor

Worcester HIV Vaccine

Collaborators

[object Object]
[object Object]